COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140371260A1
SERIAL NO

14280405

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a novel drug combination therapy useful in the treatment of dementia comprising administering an 1-aminocyclohexane derivative such as memantine or neramexane and an acetylcholinesterase inhibitor (AChEI) such as galantamine, tacrine, donepezil, or rivastigmine.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERZ PHARMA GMBH & CO KGAAFRANKFURT AM MAIN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Moebius, Hans-Joerg Frankfurt Am Main, DE 11 174

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation